/ Unknown statusNot Applicable A Randomized, Controlled, Multicenter Clinical Trial to Evaluate the Efficacy and Safety of Sheng Bai Oral Liquid in Prevention and Treatment for The Decrease of Neutrophils After Chemotherapy in Patients With Non-Small-Cell Lung Cancer
The purpose of the study is to evaluate the efficacy and safety of Sheng Bai oral liquid in prevention and treatment of the decrease of neutrophilics after chemotherapy in patients with non-small-cell lung cancer.
/ Unknown statusNot Applicable Clinical Trial of Elemene Injection/Elemene Oral Emulsion in Combination With Systematic Chemotherapy Including Oxaliplatin in the First -Line Treatment of Advanced Primary Liver Cancer
Clinical Trial of Elemene Injection/Elemene Oral Emulsion in Combination with Systematic Chemotherapy including Oxaliplatin in the First -line treatment of advanced primary liver cancer
/ Unknown statusNot Applicable Clinical Trial of Elemene Injection/Elemene Oral Emulusion in Combination With the Best Supportive Treatment in the Treatment of Advanced Primary Liver Cancer
Clinical Trial of Elemene Injection/Elemene Oral Emulusion in Combination With the Best Supportive Treatment in the Treatment of Advanced Primary Liver Cancer
100 Clinical Results associated with BeiJing Yijiayi Medicine Techonoloy Co., Ltd.
0 Patents (Medical) associated with BeiJing Yijiayi Medicine Techonoloy Co., Ltd.
100 Deals associated with BeiJing Yijiayi Medicine Techonoloy Co., Ltd.
100 Translational Medicine associated with BeiJing Yijiayi Medicine Techonoloy Co., Ltd.